Institut de Radioprotection et de Surete Nucleaire
Quick facts
Phase 2 pipeline
- Radioiodine · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: